New Study on People’s Response to Information from Direct-to-Consumer Genetic Testing

October 08, 2020
Studying the impact of direct-to-consumer genetic testing on consumers, 23andMe scientists found that people who received information about genetic risk for a certain type of blood clots, found it useful, and in some cases, took actions to lower their risk.
Read More

23andMe+: An ongoing approach to your genetics

October 01, 2020
Starting today, we are offering current 23andMe health service customers in the U.S. access to 23andMe+, a new annual membership. This membership provides customers with exclusive access to genetic reports,...
Read More

23andMe’s Commitment to Diversity, Equity & Inclusion

September 30, 2020
Last June, following the tragic deaths of George Floyd and so many others in the Black community, our CEO pledged to hold ourselves accountable to make improvements to ensure our...
Read More

Making Good of Your Time

September 02, 2020
Jamie's experience volunteering at Camp Champ helped to lead 23andMe to add a new Volunteer Time Off benefit for all its employees.
Read More

At 23andMe It Starts with Privacy

August 26, 2020
Securing and protecting that data is paramount to 23andMe. We're committed to keeping our customers' trust and providing a secure place where they can explore their DNA, knowing their privacy is protected. That starts with giving our customers a choice in whether their data is shared. We also want our customers to clearly understand how their data might be used if they choose to share it, and by whom.
Read More

23andMe and GSK Begin First Clinical Trial with Cancer Therapy

July 29, 2020
A drug to fight cancer will be the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration as the two companies announced that the new therapy will begin clinical trials.
Read More

Introducing L. Okey Onyejekwe Jr.

July 27, 2020
We sit down for a chat with L. Okey Onyejekwe Jr., 23andMe's new vice president of Consumer Clinical Operations & Medical Affairs.
Read More